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Summary
Objective: To determine how acute synovitis, with and without intra-articular methylprednisolone acetate (MPA),
affect synthesis of proteoglycan, total protein, and collagen in articular cartilage and total protein synthesis in
synovial membrane.
Design: Synovitis was induced in 10 ponies by the injection of 0.5 ng lipopolysaccharide (LPS) into the left
radiocarpal and midcarpal joints every 2 days for a total of four treatments. Synovitis was documented by clinical
examination and synovial fluid analyses. Two days before euthanasia, MPA (0.1 mg/kg) was injected with the last dose
of LPS into both the left and right radiocarpal and midcarpal joints of five of these ponies. Proteoglycan synthesis
in articular cartilage explants from these joints was measured by incorporation of sodium [35S]sulfate. The size of the
proteoglycan monomers and their aggregation with hyaluronan was assessed by size-exclusion chromatography.
Protein synthesis in articular cartilage was measured by incorporation of [3H]proline and collagen synthesis by
conversion of [3H]proline into [3H]hydroxyproline. Protein synthesis was measured in synovial membrane explants by
incorporation of [35S]methionine.
Results: Ponies developed carpal effusion and mild lameness accompanied by increased total nucleated cell count
and total solids in synovial fluid in response to the LPS injections. Moderate to severe synovial membrane proliferation
and inflammation were observed histopathologically in joints injected with LPS but no consistent light-microscopical
changes were observed in the articular cartilage from these joints. Intra-articular MPA alone was associated with
decreased proteoglycan synthesis and increased protein and collagen synthesis in the cartilage explants. Total protein
synthesis by synovial membrane was also increased by MPA alone. In contrast, no differences in protein or
proteoglycan synthesis were observed in explants from the joints with synovitis, with or without intra-articular MPA.
Treatment with MPA, LPS, and LPS/MPA did not alter proteoglycan aggregate size, but LPS-induced synovitis
resulted in an increase in the second largest population of monomers. MPA increased the synthesis of small
proteoglycan monomers.
Conclusion: Based on the methods used, acute synovitis prevented changes induced by intra-articular MPA alone.
Results suggested that the effect of intra-articular MPA on joint metabolism was different between inflamed and
normal joints. Experimental studies must consider the effect of inflammation, as well as the potential to introduce
in vitro culture artifacts when investigating the effect of intra-articular corticosteroids on chondrocyte function.
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Introduction
Synovitis has been implicated in the initiation of
osteoarthritis in racehorses [1–4]. Although the
role of synovitis as a primary initiator of
osteoarthritis in humans is controversial, it has,
nevertheless, been associated with osteoarthritis
[5, 6] and with the intermittent exacerbations that
occur in this disease [7, 8]. Synovitis results in
release of cytokines like interleukin-1 and tumor
necrosis factor a [4, 9, 10], which down-regulate
matrix synthesis in isolated chondrocytes and
cartilage explants [11–14]. However, articular
cartilage matrix synthesis was increased in models
of osteoarthritis in dogs [15–17] and there was a
trend (P = 0.06) toward an increase in equine joints
with synovitis [18]. Steady-state mRNA levels of
aggrecan and type II procollagen were increased
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significantly in cartilage from equine joints with
lipopolysaccharide (LPS)-induced synovitis [19].
Corticosteroids are potent anti-inflammatory
drugs for treatment of inflamed joints and are
widely used in humans [20] and horses [21].
Although helpful in relieving symptoms of joint
inflammation, experimental evidence indicates
that intra-articular corticosteroids like methyl-
prednisolone acetate (MPA) (Depomedrol8, Up-
john) cause loss of basophilia and decreased
intensity of safranin 0 staining of articular
cartilage, chondrocyte necrosis, decreased proteo-
glycan content, decreased collagen synthesis,
increased water content and delayed healing of
experimentally-induced osteochondral defects [22–
31]. A similar effect of corticosteroids on articular
cartilage in horses [32] and other species [26–
28, 33] occurs in vitro. Keratan sulfate, a marker of
articular cartilage degradation [34–36], was elev-
ated significantly in the synovial fluid of ponies
treated 21 days previously with intra-articular
MPA [21]. It has been shown in rats [37], horses
[38], and in vitro in dogs [39], that the degenerative
processes induced in articular cartilage by intra-
articular corticosteroids (‘steroid-induced
arthropathy’) render the tissue more susceptible to
mechanical injury. Despite the experimental data
that intra-articular corticosteroids damage articu-
lar cartilage, the controversy over the relationship
between their therapeutic benefits as anti-inflam-
matory agents and the occurrence of ‘steroid-in-
duced arthropathy’ continues [20]. Part of the
problem in explaining the difference between
clinical response and results of experimental data
may reside in the experimental model used and the
dose of corticosteroid administered [20, 29–31, 39–
41].
We propose that the effect of intra-articular
corticosteroids on joint metabolism is influenced
by dose [32], joint use [38] and the local joint
environment. We recently demonstrated that
dynamic load counteracted the effect of moderate
doses of methylprednisolone sodium succinate
(Solumedrol8, Upjohn) in vitro [38] and that the
response of articular cartilage to cytokine-in-
duced injury in vitro depended on the dose of
corticosteroid used as well as whether the
cartilage had been treated with cytokines before
treatment with corticosteroids [41]. The objective
of the current study was to compare the effects of
synovitis and intra-articular MPA on cartilage
and synovial membrane gene expression and
metabolism in the carpal joints of rested ponies.
Here, we present the protein synthesis data and
compare it to transcriptional data that has been
reported elsewhere [19].
Materials and Methods
Ten ponies were used ranging in age from 2–3
years and in weight from 200–300 kg. The 20 carpi
from these 10 ponies were assigned to one of four
experimental groups. All ponies received 0.5 ng
LPS (Sigma, St. Louis, MO, U.S.A.) into the left
radiocarpal and midcarpal joints every other day
for a total of four injections (Fig. 1). Preliminary
studies showed that 0.5 ng LPS produced a
consistent inflammatory response in ponies com-
pared with the 0.125 ng described by Palmer and
Bertone in horses [42]. In five of these ponies,
0.1 mg/kg of MPA was administered into the left
radiocarpal and midcarpal joints (with the last
dose of LPS) and into the contralateral joints on
the right limb. We considered this a moderate dose
of intra-articular MPA (about half of that often
injected into carpal joints of horses clinically), but
we injected this into both carpal joints of each
forelimb (Fig. 1). The other five ponies received no
MPA in either carpus. Therefore, there were four
different joint treatments, but the joint treatments
were confounded within pony in that each pony
received only two of the four treatments. Venous
blood for complete hemograms was collected on
days 0, 4, 7, and 8 during the experiment. Carpal
synovial fluid was collected into sodium EDTA on
the same days. Total solid concentration and
nucleated cell count were measured on synovial
fluid and the distribution of these cells was
assessed. Ponies were euthanized on day 8 with an
overdose of pentobarbital sodium.
histopathology
The carpal joints were opened aseptically,
examined and photographed. Synovial membrane
was collected from the dorsolateral aspect of the
carpal joints (Fig. 1), fixed in 10% phosphate-
buffered formalin, embedded in paraffin, sectioned
at 6 mm and stained with hematoxylin and eosin.
Histopathological evaluation of the synovial
membrane was performed by a pathologist (K.P.F.)
unaware of treatment assignments. The degree of
inflammation as judged by the cellular infiltrate,
the proliferation of synovial lining cells, and the
amount of fibrous tissue was graded from the least
inflamed (0) to the most severely inflamed (4)
[43, 44].
Articular cartilage and attached subchondral
bone was collected from the dorsomedial radial
carpal bone (Fig. 1), decalcified in 10% formic acid,
dehydrated, embedded in paraffin, sectioned at
6 mm, and stained with safranin O/fast green or
hematoxylin and eosin. Cartilage was evaluated
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Fig. 1. Diagram shows the location of the carpal joint in the horse and the insert shows the distal surface of the
proximal row and the proximal surface of the distal row of carpal bones. The location of the articular cartilage sample
taken from the radial carpal bone for histopathology is shown (a). Synovial membrane was sampled from the dorsal
(anterior) surface of this joint.
for surface architecture, chondrocyte morphology,
and pericellular, territorial, and interterritorial




Eight-millimeter-diameter cartilage discs (ex-
cluding calcified cartilage) were excised asepti-
cally from the proximal and distal intermediate
carpal bone (Fig. 1) with a dermal biopsy punch
and scalpel blade. The discs were pooled, washed,
allocated randomly into individual wells and
incubated in defined, serum-free, medium based on
Ham’s F12 (Gibco, Grand Island, NY, U.S.A.) which
contained a supplement with insulin (ITSCR+,
Collaborative Research, Bedford, MD, U.S.A.) and
included ascorbate and CaCl2 [46]. Cartilage was
incubated at 10 mg wet wt/ml medium. Explants
were incubated at 37°C, 90% humidity, 5%
CO2/95% air, in quadruplicate, with 20 mCi/ml of
sodium [35S]sulfate for 6 h. The average time
between euthanasia and initiation of radiola-
belling was 7 h. Following radiolabelling, the
explants were washed in ice-cold Gey’s balanced
salt solution (Gibco) and frozen at −70°C.
Explants were digested with papain (1.0 mg/ml)
(Sigma) at 0.1 ml per 10 mg wet wt at 65°C for 8 h
[47]. Radioisotope incorporation was measured
with scintillation counting. Sulfated glycosamino-
glycan content of the explants was determined
Fig. 2. Graph showing changes in the total nucleated cell
count (TNCC; – – –) and total solids (TS; ——) of
synovial fluid from equine carpal joints with LPS-in-
duced acute synovitis. Values are the least squares
mean 2 s.e.m. of measurements on synovial fluid taken
from the radiocarpal and midcarpal joints of five ponies
on the days indicated. The ponies were injected with
LPS on days 0 (after collection of the initial synovial
fluid sample), 2, 4, and 6.
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Fig. 3. Photomicrographs of synovial membrane from
normal (a) and inflamed (b) midcarpal joints of ponies.
(a) Normal synovial membrane consisting of a layer of
lining cells (1–2 cells thick) adherent to the subintima.
(b) The synovial membrane following four injections of
0.5 ng of LPS is hypertrophic and hyperplastic ac-
companied by cellular infiltration and fibrovascular
subintimal proliferation. Bar = 20 nm. Hematoxylin and
eosin stain.
monomers were chromatographed dissociatively
on a Sepharose CL2B (Pharmacia, Piscataway,
NJ, U.S.A.) column. The columns were calibrated
with ferritin, dextran blue, and bromphenol blue.
All samples were chromatographed with brom-
phenol blue to ensure that chromatographic
conditions remained constant. For associative
chromatography, extracts containing 100 000
counts/min were concentrated to 100 ml and diluted
to 0.4 m guandinium chloride by adding 700 ml
of 0.1 m Na2SO4 and 0.05 m NaAc in 0.1% Triton
X-100 at pH 6.1. Hyaluronan (Healon8, Pharmacia)
was prepared at 2.0 mg/ml in the same buffer and
added to the extract to a final concentration
of 0.4 mg/ml. The extract was then chromato-
graphed associatively on a Sepharose CL2B
column. Column eluant was collected in fractions,
radioactivity was measured with scintillation
counting and sulfated glycosaminoglycans in




Separate cartilage discs were incubated in
Dulbecco’s modified Eagle’s medium (Gibco) which
contained a supplement with insulin (ITSCR+,
Collaborative Research), ascorbate and CaCl2 [46].
Cartilage was incubated for 6 h in quadruplicate at
10 mg wet wt/ml medium containing 40 mCi/ml of
[3H]proline at 37°C, 90% humidity, 5% CO2/95%
air. Following radiolabelling, the explants were
placed in fresh medium without radiolabel and
chased for 8 h under the same conditions to
maximize incorporation of [3H]proline. The ex-
plants were washed in ice-cold 50% ethanol and
frozen at 70°C. Collagen synthesis was measured as
[3H]proline incorporation into [3H]hydroxyproline
as described [32]. Collagen synthesis was expressed
as counts per minute. [3H]hydroxyproline per
microgram dry weight cartilage and total protein
synthesis as total counts per minute in the
combined [3H]proline and [3H]hydroxyproline
peaks per microgram dry weight cartilage.
protein synthesis
Synovial membrane
Synovial membrane was collected aseptically
from the dorsolateral aspect of the midcarpal
joint (Fig. 1) and incubated in quadruplicate in
Dulbecco’s Modified Eagle’s Medium sup-
with the dimethylmethylene blue dye-binding
(DMMB) assay [47]. Proteoglycan synthesis was
expressed as counts per minute/mg glycosaminogly-
can.
Size-exclusion chromatography
Cartilage explants from two ponies (four carpi,
representing each treatment group) were radio-
labelled with sodium [35S]sulfate (20 mCi/ml) for 6 h
and washed to remove free radioactive sulfate.
Proteoglycans were extracted with 4 m guani-
dinium chloride containing protease inhibitors,
concentrated (Amicon Concentrators, Amicon
Inc., Beverly, MA, U.S.A.; 30 000 molecular weight
cut-off) by centrifugation (100 000 counts/min
concentrated to 1.0 ml), and proteoglycan
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plemented with insulin (ITSCR+), ascorbate, and
CaCl2. Explants were incubated at 20 mg wet wt/ml
medium at 37°C, 90% humidity, 5% CO2/95% air,
with 10 mCi/ml [35S]methionine for 6 h. Following
radiolabelling, the explants were washed gently
in ice-cold Gey’s balanced salt solution (Gibco)
and frozen at −70°C. Proteins were extracted
from explants with 4 m guanidinium chloride
followed by 1 m sodium hydroxide. Proteins
were precipitated on filters with perchloracetic
acid and unincorporated radiolabel was removed
by washing. Radioactivity in the protein precipi-
tate was counted in scintillation fluid and
expressed per miocrogram protein in the mem-
brane which was estimated by the Coomassie
blue assay (Peirce Chemical Co., Rockford, IL,
U.S.A.).
statistical methods
Measurements on synovial fluid were loge
transformed and analyzed with a mixed model
analysis of variance for repeated measures in
which the pony was random and the joint
treatment was fixed within pony. Synthesis
measurements were expressed as a percent of
the control joint, loge transformed, and analyzed
with a mixed model analysis of variance with
P Q 0.05 considered significant. Linear contrasts
were constructed to determine differences
between control and treated joints and correlation




Ponies remained normothermic with no changes
in hemograms. LPS-treated carpi had carpal
effusion and ponies showed minimal lameness
accompanied by a positive response to flexion test.
Synovitis was accompanied by a significant
increase in total nucleated cell count and total
solids over the course of the experiment except
that total solids fell between day 7 and day
8 (Fig. 2). There was no significant effect of
MPA on total cell count or total solids in synovial
fluid of joints with, or without, LPS-induced
synovitis.
histopathology
Both the LPS- and LPS/MPA-treated joints
had moderate to severe inflammatory changes
(mean score 3.5) while the MPA-treated and
control joints had mild to no inflammatory
changes (mean score 0.5) (Fig. 3). There were no
significant differences between groups based
on histopathologic examination of articular carti-
lage.
proteoglycan synthesis
MPA caused a significant decrease in proteo-
glycan synthesis in carpal articular cartilage
compared with all other treatment groups
(Fig. 4). There was no difference between proteo-
glycan synthesis in cartilage from control
joints or those treated with LPS or LPS/MPA
(Fig. 4).
size-exclusion chromatography
When extractable proteoglycans were chromato-
graphed dissociatively, most of the radioactive
sulfate was incorporated into aggrecan monomers
that eluted first from the column and not into the
smaller (later-eluting) proteoglycans when com-
pared to the proportion of small proteoglycans in
Fig. 4. Histogram showing corticosteroid- and synovitis-
induced changes in proteoglycan synthesis in equine
articular cartilage. Carpal cartilage explants were
harvested from ponies in the four experimental groups
described in the Materials and Methods. Quadruplicate
explants were radiolabelled with [35S]sulfate to measure
proteoglycan synthesis. Data are expressed as least
squares mean 2 s.e.m. and as a percent of control joint
synthesis. MPA, methylprednisolone acetate; LPS,
lipopolysaccharide. Different letters indicate P Q 0.05
between treatment groups.
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total extractable proteoglycans (Fig. 5). Total
proteoglycans, as measured by the DMMB as-
say, eluted in three populations; two major
overlapping peaks eluting initially and one
peak of small proteoglycans eluting later. Treat-
ment with MPA [Fig. 5(c)] increased the synthesis
of a population of small proteoglycan mono-
mers compared to the proportion of small
proteoglycans in total proteoglycans extracted
from control cartilage. LPS induced an increase
in the second largest population of monomers
based on an increase in the size of the second
largest peak in the elution profile relative to
the size of the first peak and a decrease in the
slope of this peak between fractions 65
and 80 [Fig. 5(b)]. The combined effects of both of
these treatments were apparent in extracts of
cartilage from joints treated with LPS/MPA
[Fig. 5(d)].
When extractable proteoglycans were chro-
matographed associatively, little change was
observed in elution location (Fig. 6).
protein synthesis in cartilage
Collagen [Fig. 7(a)] and total protein
[Fig. 7(b)] synthesis in explants from joints
treated with MPA were significantly higher
than synthesis in the explants from the con-
trol joints. Collagen and total protein synthesis
in explants from LPS- or LPS/MPA-treated
joints were not significantly different to
synthesis in explants from control joints,
although synthesis in these joints tended to be
higher than synthesis in control joints. There
was a strong positive correlation (r = 0.88,
P Q 0.0001) between collagen and total protein
synthesis, but no significant correlation between
synthesis of proteoglycan and collagen by
cartilage.
Fig. 5. Elution profiles of size-exclusion dissociative
chromatography. Sepharose CL2B columns were
calibrated with blue dextran, ferritin and bromphenol
blue. Bromphenol blue was added to all samples to
check for consistent elution location. Proteoglycans
in cartilage explants were labelled with sodium
[35S]sulfate and extracted with 4 m GuHCl. Proteogly-
cans were chromatographed dissociatively in
4 m GuHCl. Fractions were collected and scintilla-
tion counted (closed circles) and sulfated gly-
cosaminoglycans (open circles) were measured with the
dimethylmethylene blue dye-binding assay. (a)–(d)
elution profile of dissociative chromatography of
proteoglycans extracted from cartilage of control (a),
LPS-injected (b), MPA-injected (c), and LPS/MPA-in-
jected (d) joints.
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protein synthesis in synovial membrane
Total protein synthesis in the synovial mem-
brane was significantly higher in MPA-treated
joints than in control joints (Fig. 8). There was no
difference in protein synthesis in synovial mem-
brane from joints treated with LPS or LPS/MPA
compared with control joints.
Discussion
Several main points arise from our study: the
synovitis we induced in the carpal joints of ponies
did not progress to histologic evidence of osteo-
arthritis within the time frame of the study.
However, our transcriptional data reported else-
where [19] clearly showed that synovitis signifi-
cantly increased steady-state levels of type II
procollagen mRNA (a six- to sevenfold elevation)
and, to a lesser extent, aggrecan core protein
mRNA (a twofold elevation). Our synthesis data
did not corroborate this effect and we shall offer a
possible explanation for this dichotomy. Neverthe-
less, the effect of intra-articular MPA on synthesis
of both collagen and proteoglycan by cartilage
explants was affected by the presence of synovitis.
Finally, intra-articular MPA caused the synthesis
of a population of small proteoglycans which may
affect cartilage function.
The experimental model of intra-articular injec-
tion of subnanogram amounts of LPS to induce
synovitis in horses was described originally by
Palmer and Bertone [42]. Intra-articular injection
of LPS induces an acute phase response [48].
Significant increases in interleukin-1, interleukin-
6, and tumor necrosis factor-a have also been
measured in naturally-occurring acute and severe
chronic synovitis in horses [10]. The dose of LPS
used in the current study induced negligible
lameness with no systemic effects or clinical signs
of endotoxemia. Therefore, the contralateral joint
Fig. 6. Elution profiles of size-exclusion, associative
chromatography. Sepharose CL2B columns were cali-
brated with blue dextran, ferritin and bromphenol blue.
Bromphenol blue was added to all samples to check for
consistent elution location. Proteoglycans in cartilage
explants were labelled with sodium [35S]sulfate and
extracted with 4 m GuHCl. Proteoglycans were chro-
matographed associatively in 0.4 m GuHCl after addition
of exogenous hyaluronan. Fractions were collected and
scintillation counted (closed squares) and sulfated
glycosaminoglycans (open squares) were measured with
the dimethylmethylene blue dye-binding assay. (a)–(d)
elution profile of associative chromatography of proteo-
glycans extracted from cartilage of control (a), LPS-in-
jected (b), MPA-injected (c) and LPS/MPA-injected (d)
joints.
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can be used as an untreated control. At the dose of
0.5 ng LPS/joint, we did not observe significant
changes in articular cartilage morphology as
described by Todhunter et al. [45] who used 3 mg
LPS per injection. They observed decreased uptake
of the histochemical stain toluidine blue, chondro-
cyte hypertrophy, and expression of glycosamino-
glycans containing the 3-B-3 epitope which is
considered to be a marker of cartilage injury and
repair [49]. These findings are consistent with
induction of the hypertrophic phase of osteo-
arthritis. We presume that the lack of effect that
we observed on cartilage morphology in the
current study was due to the very low dose of LPS
and the short (8-day duration) experiment.
Although we observed no systemic effects of LPS,
any amount of intra-articular LPS might affect the
metabolism in the contralateral joint. If there was
any undetectable effect, it was also accounted for
by the mixed model analysis of variance in which
the least squares means adjust for the baseline
level of synthesis in each pony. Nevertheless, the
model did permit us to show an interaction
between synovitis and intra-articular MPA. Differ-
ent amounts of either LPS or MPA may have
produced more dramatic results, but the negligible
pain induced by our model was advantageous and
we chose a moderate dose of intra-articular MPA
that approximates amounts used in clinical
situations.
Proteoglycan synthesis in cartilage was de-
pressed by MPA and this effect was abrogated in
the presence of synovitis. However, there was no
increase in proteoglycan synthesis in response to
acute synovitis as reported by others [15–
17, 50, 51]. The P-value in Palmer et al.’s study [18]
on the effect of LPS-induced synovitis in equine
joints did not reach significance at an a level of
0.05. Steady-state levels of aggrecan mRNA
isolated directly from articular cartilage in these
same carpal joints was increased twofold by
synovitis [19]. Although we expected transcrip-
tional changes in the expression of aggrecan and
other matrix macromolecules in cartilage to be
followed by parallel translational changes in the
synthesis of the corresponding macromolecules,
this was not observed. For the translational
experiments, we performed our radiolabeling as
soon as possible after tissue explantation. Intra-
articular injection of radiolabel would be prefer-
able but difficult to control radioactive contami-
nation in a large animal. Another option would
Fig. 7. (a) Histogram showing corticosteroid- and
synovitis-induced changes in total collagen synthesis in
equine articular cartilage. Carpal cartilage explants
were collected from ponies in the four experimental
groups described in Materials and Methods. Explants
were radiolabelled in quadruplicate with [3H]proline and
incorporation into [3H]hydroxyproline was used as a
measure of collagen synthesis. Data are expressed as
least square means 2 s.e.m. and as a percent of control
joint synthesis. MPA, methylprednisolone acetate; LPS,
lipopolysaccharide. Different letters indicate P Q 0.05
between treatment groups. (b) Histogram showing
corticosteroid- and synovitis-induced changes in total
protein synthesis in equine articular cartilage. Carpal
cartilage explants were collected from ponies in the four
experimental groups described in Materials and
Methods. Explants were radiolabelled with [3H]proline
and total incorporation of [3H]proline was used as a
measure of total protein synthesis. Data are expressed as
least square mean 2 s.e.m. and as a percent of control
joint synthesis. MPA, methylprednisolone acetate; LPS,
lipopolysaccharide. Different letters indicate P Q 0.05
between treatment groups.
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protein synthesis compared with control joints.
Again, these translational data did not support the
transcriptional results in which decreased steady-
state COL2A1 mRNA levels were observed in these
same joints from cartilage processed immediately
after euthanasia and without an in vitro culture
period [19]. Therefore, the increased synthesis of
collagen and protein by cartilage explants as a
result of MPA treatment is probably due to either
a residual protective effect of MPA on chondrocyte
function following explantation or to a rebound
phenomenon that occurs when cartilage explants
are cultured following earlier in vivo suppression
of synthesis caused by MPA [41]. We have
previously interpreted similar results from in vitro
experiments as evidence that low doses of MPA
stimulated collagen and protein synthesis in
cartilage explants [32]. However, it is now
apparent that we should consider the possibility of
a rebound effect on synthesis during the radiola-
belling and chase period based on the more recent
data. A rebound phenomenon may also explain the
effect of MPA on protein synthesis observed in the
synovial membrane explants.
Synovial inflammation prevented the de-
pression of chondrocyte proteoglycan synthesis
and the increase in collagen synthesis observed
with treatment by MPA alone. The effect of
corticosteroids on proteoglycan synthesis in
equine cartilage explants [41] and isolated chon-
drocytes [52] is partially abrogated by prior
exposure to cytokines. Intra-articular MPA may
be removed rapidly from an inflamed joint,
dilutional effects from the synovial effusion on
the concentration of MPA may play a role,
inflammatory cytokines and growth factors in
synovial fluid may alter chondrocyte gene ex-
pression [19], and glucocorticoid receptor levels
in synovial tissue may have been decreased in
the inflamed joint [53].
Molecular mechanisms of corticosteroid action
and interactions between corticosteroids and
cytokines may partly explain our findings and
the sometimes contradictory results of studies
involving normal [29–31] and diseased [39, 40, 62–
66] joints. Binding of the activated steroid–recep-
tor complex to DNA modulates the transcription
of genes that have functional steroid–response
elements [54, 56]. Thus, depending on the gene,
transcriptional modulation can be positive or
negative [55]. Our data reported here indicate
that the duration of the effect appears to vary
for the aggrecan core protein gene compared to
the COL2A1 gene and according to the dose of
corticosteroid [41]. The competitive interaction
between the steroid–receptor complex and
have been to radiolabel the whole bone immedi-
ately upon excision. However, this presented
logistical problems and increased the risk of
radioactive contamination and cost. In the 7 h that
elapsed between cartilage collection and initiation
of radioactive labelling and the 6 h of the pulse, the
anabolic response to inflammation may have faded.
Another point to consider, however, is that
transcriptional and translational events are not
necessarily tightly correlated. Translational regu-
lation, post-translational modifications, cyto-
plasmic transport and secretion rates can affect
protein synthesis.
MPA induced the synthesis of the smallest
proteoglycan eluting between fraction 85–90
[Figure 5(c) and (d)]. This small proteoglycan may
affect cartilage function or integrity. We have
observed this effect previously in vitro following
treatment of cartilage with MPA [32]. This change
in proteoglycan synthetic profile may reflect a
partial ‘de-differentiation’ of the chondrocytes
toward a more fibroblastic phenotype and warrants
further investigation.
In contrast to MPA-induced suppression of
aggrecan synthesis, explants from joints treated
with MPA had increased collagen and total
Fig. 8. Histogram showing corticosteroid and synovitis-
induced changes in total protein synthesis of equine
synovial membrane. Carpal synovial membrane explants
were collected from ponies in the four experimental
groups described in Materials and Methods. Explants
were radiolabelled with [35S]methionine and incorpor-
ation into total protein was measured following
extraction. Data are expressed as least squares
mean 2 s.e.m. and as percent of control joint synthesis.
MPA, methylprednisolone acetate; LPS, lipopolysaccha-
ride. Different letters indicate P Q 0.05 between treat-
ment groups.
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cFos cJun heterodimers [56–58] and an MPA-in-
duced increase in inhibitory factor of nuclear
factor Kappa B [59, 60] will also affect the manner
in which corticosteroids affect inflammation.
Combined, the presence of these multiple
variables may help to explain apparent contradic-
tions between in vitro and in vivo data and why
‘corticosteroid-induced arthropathy’ has been
difficult to study and explain at both a clinical and
experimental level. Furthermore, it appears clear
that caution should be exercised when extrapolat-
ing the detrimental effects of intra-articular MPA
on normal joints to their clinical effects in
inflamed joints.
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